Organizers of the 3rd IAASS 2016: scientific curricula & career path.
Enzo Tramontano holds a degree (1990)from the University of Cagliari (Italy), he was Visiting Research Scientist at the Dept. of Pharmacology at Yale University Medical School (CT, USA, 1990-1992 and 1996-1998). He was given two awards granted by the Istituto Superiore di Sanità for “Research in the HIV field: AIDS Project”, for research activities performed in national (1993-1995) and international (1996-1998) institutions. Since 1998 he has worked at the Departments of Experimental Biology (1998-2003), Biomedical Sciences and Technologies (2003-2007), Applied Sciences in Biosystems (2007-2010) and Life and Environmental Sciences (2011-2016) at the University of Cagliari, being appointed as Research Associate (1998), Assistant Professor (2001), Associate Professor (2006) and Full Professor (2015). From 2015 he is also associated to the Institute of Genetic and Biomedical Research of the National Research Council (CNR) in Cagliari. Since 2006 he is head of the Molecular Virology laboratory of the Department of Life and Environmental Sciences of the University of Cagliari. From 2012 to 2015 he has been Vice-Director of the Department of Life and Environmental Sciences, from 2013 is Director of the PhD program in “Life, Environmental and Drug Sciences” and from 2015 he is Dean of the Faculty of Biology and Pharmacy of the University of Cagliari. He is founder member of the European Society of Virology, the International Society for Antiviral Research (for which he is Ambassador for Italy), the Italian Society of Virology and the Italian Society of General Microbiology and Microbial Biotechnologies (for which is currently member of the Executive Council).
Elias Maccioni (1966) holds a degree from the University of Cagliari, Italy, (1990) and was appointed Assistant Professor of medicinal chemistry in 1992. In 1993 to 1994 he was Visiting Researcher at the Department of Chemistry of the University of Bangor, North Wales. In 2005 he was appointed Associate Professor of Medicinal Chemistry at the Faculty of Pharmacy of the University of Cagliari. He now leads a research group of Drug Discovery at the Department of Life and Environmental Sciences of the University of Cagliari. He is member of the Italian society of Medicinal Chemistry and coordinates the PhD school of Medicinal Chemistry at the University of Cagliari. Moreover he is coordinator of the Paul Ehrlich Network of European Medicinal Chemistry PhD for the University of Cagliari. His research is mainly directed towards the design and synthesis of HIV 1 reverse transcriptase and human monoamine oxidase inhibitors.
Cristina Parolin received the Bachelor Degree in Biology (1988), the PhD in Basic and Applied Microbiology (1995) from the University of Padova and the Specialty diploma in Microbiology and Virology (1998) from the University of Genova. She was “Research fellow” and Research Associate (1991-1997) at the Dana-Farber Cancer Institute, Harvard Medical School, Boston. She was appointed as Research Associate (1998) and Assistant Professor (2001) at the University of Padova, where she is now Professor in Microbiology since 2006 (Department of Molecular Medicine). Member of the Italian Society of Virology (Board 2008-); Italian Society of General Microbiology and Microbial Biotechnologies (Board) (2003-2006); International Committee for Taxonomy of Viruses (ICTV) (Italian representative) (from 2004); European Society for Virology (from 2009). Author of publications on national and international “peer-reviewed” journals. Major research interests are: studies on the mechanism of action of antiviral compounds; development of retroviral vectors for transgene expression (1995: “European Gene Therapy Award – Fondazione Baschirotto”; 1997: LINUS PAULING AWARD; patent for heterologous gene expression by means of an HIV-1 vector “Novel expression vectors and method of use”, PCT/US96/16531); lentivirus biology (life cycle, HIV/herpesviruses interactions and role on AIDS pathogenesis); interactions between viral and cellular proteins in order to identify potential targets for antiviral approaches.
Stuart Le Grice received his Ph.D. from the Department of Biochemistry, University of Manchester, UK, in 1976, where he studied the mechanisms of R-factor-mediated multidrug resistance in Escherichia coli. After postdoctoral training in the United Kingdom, Germany, and the United States, he was appointed Senior Scientist in the Central Research Units of Hoffmann La Roche, Basel, Switzerland, where he worked from 1984 to 1990 evaluating HIV-1 and HIV-2 enzymes as therapeutic targets. In 1990, he joined the faculty in the Division of Infectious Diseases, Department of Medicine, Case Western Reserve University (CWRU), Cleveland, OH. Initially recruited as an Associate Professor of Medicine, he was awarded tenure in 1992, and in 1995 was promoted to Professor of Medicine, Biochemistry, and Oncology. From 1994 to 1999, he served as Director of the NIH-funded CWRU Center for AIDS Research. Dr. Le Grice joined the National Cancer Institute in 1999 as Chief of the Resistance Mechanisms Laboratory in the HIV Drug Resistance Program, Center for Cancer Research (CCR), and in 2005 was appointed to the Senior Biomedical Research Service. In 2006, he was appointed Head of the Center of Excellence in HIV/AIDS & Cancer Virology, CCR. He is now head of the Basic Research Laboratory at the Center for Cancer Research of the National Cancer Institute. He is a member of the CCR HIV and Cancer Virology faculty, Chemistry and Biology faculty, and the Steering Committee of the Molecular Targets Discovery Program. In addition to serving on the Editorial Board of the Journal of Biological Chemistry, Dr. Le Grice has been an ad hoc (1990-1999) and permanent Study Section member of NIH AIDS review panels (2000-2004), as well as an ad hoc reviewer for several international funding agencies.
Katarzyna Purzycka earned her Bachelor Degree in Chemistry from the Poznan University in Poland in 2004. In 2009 she was awarded her PhD in Biochemistry from the Institute of Bioorganic Chemistry, Polish Academy of Sciences, where she studied HIV-2 RNA and its nucleoprotein complexes as potential therapeutic targets. She continued her studies on retroviral RNAs during her postdoctoral training at the National Cancer Institute, NIH, USA. In 2012 she was appointed Assistant Professor of Biochemistry at the Institute of Bioorganic Chemistry, Polish Academy of Sciences, where she is now head of the Retroelements’ Structure and Function Laboratory. DrPurzycka was a visiting professor at the University of Georgia, USA and she is a recipient of several awards, including MNiSW fellowship for outstanding young scientist. Her major scientific interests are RNA structural elements and transitions on both 2D and 3D structural levels that specify RNA functions at different stages of retrovirus and endogenous retrovirus-like retrotransposon replication.